Center for Transformative Infectious Disease Research (CTIDR) at Cornell
Official title: Center for Transformative Infectious Disease Research (CTIDR)
Funded at Cornell University · NIH-11421469 · Data updated 2026-11-12
A research center at Cornell aims to create predictive health tools and preventative measures for infectious diseases influenced by weather, by engaging communities and studying how humans, animals, and the environment interact.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project start | September 17, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $220,237 |
| NIH project number | 5P20AI186093-03 |
| Project ID | NIH-11421469 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include people living in areas affected by vector-borne diseases and communities willing to participate in community-engaged research and data sharing.
✕Less likely to help
Communities not participating in engagement activities or in areas with no risk of vector-borne disease may see limited direct benefit.
What this research studies
This grant funds a center focused on understanding how weather, land use, and behavior of people, animals, and vectors drive infectious disease risk. It emphasizes community engagement and data integration to build predictive models and test prevention strategies. The work will connect human health data with animal and vector biology, weather patterns, and genomic evolution to foresee and reduce spillover and vector-borne transmission. It seeks to move from reactive outbreak response to proactive prevention through collaborative, community-driven research.
Why it matters
Potential benefit: If successful, the project could lead to better early warnings and targeted interventions to protect communities from vector-borne diseases and spillover events.
How similar studies have gone: Prior research shows that integrating environmental, animal, and human data can improve outbreak prediction and prevention efforts.
Where this research is happening
-
Cornell University
Ithaca, United States Active
Researchers
- Principal investigator: Meredith, Genevive — Cornell University
- Study coordinator: Meredith, Genevive
Related research
Other NIH-funded projects on the same topics.
-
Latin American Center for Emerging Infectious Disease Surveillance and Readiness
A regional collaboration in Peru and neighboring countries aims to strengthen early warning and monitoring for viruses that could jump from animals to people, helping communities prepare for outbreaks.
-
Center in Latin America to monitor emerging infectious diseases
A U01 grant supporting a collaboration between Peruvian and U.S. researchers to improve early detection and surveillance of regionally relevant viruses that could affect people, animals, and crops in Peru and neighboring areas.
-
Acanthamoeba as a modern model parasite to study infectious disease biology and mitochondria
A five-year project will define the mitochondrial proteins and pathways of Acanthamoeba castellanii to advance infectious disease biology and parasite metabolism.
-
IDEAL project helps predict vaccine response, infections, and asthma in early childhood
A Child-focused program will collect and share saliva, blood, and tissue samples from diverse infants to find biological patterns that predict how vaccines work, how respiratory infections occur, and who develops asthma.
-
Understanding how early-life immune development affects vaccine responses and asthma risk in children
This project uses lab-grown human immune cells from infants and young children to explore why some kids respond poorly to vaccines and are more prone to respiratory infections and asthma.
-
Multi-omic endotypes of vaccine response, respiratory infections, and asthma in children
A parent-friendly look at how early-life immune development shapes how kids respond to vaccines and stay free from lung infections and asthma, using advanced biological profiling.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.